Press Room

Article / Dec 01, 2008

Risk: assessment, aversion and denial

Scrip 100 (Supplement), December 2008

Since its foundation the European Fine Chemicals Group (EFCG) has highlighted the risks and rewards globalisation brings to its members and to pharmaceutical fine chemical industry stakeholders. Guy Villax discusses the options faced by large pharma and regulators alike to meet the challenges of a fast changing industry.

Over the past 20 years, the pharma industry...

Also in the Press Room